SEC Form 4 · accession 0001144204-18-064946
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Schechter
Director
Period of report
Dec 13, 2018
Accepted (ET)
Dec 17, 2018 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F3 | $4.44 | Dec 13, 2018 | A | 7,813 | A | — | Dec 13, 2028 | Common Stock | 7,813 | 7,813 | D |
| Stock Option (right to buy)F2,F3 | $4.44 | Dec 13, 2018 | A | 1,562 | A | — | Dec 13, 2028 | Common Stock | 1,562 | 1,562 | D |
Explanation of responses
- F1These securities were issued in connection with the Reporting Person's appointment as a non-employee director to the Issuer's board of directors.
- F2These securities were issued in connection with the Reporting Person's service on the Audit Committee of the Issuer's board of directors.
- F3The stock options shall vest in equal daily installments over a three-year period beginning on the date of grant.